Browse Related Topics For:

Generic Drugs The United States Food and Drug Administration

198
Pharmaceutical Industry
112
Prescription Drugs
109
Pharmaceutical Patents
99
ANDA
96
Patents
83
Hatch-Waxman
82
Patent Infringement
70
Patent Litigation
43
Biosimilars
29
SCOTUS
26
Patent-in-Suit
26
Preemption
24
Labeling
23
BPCIA
22
FDCA
18
Medical Devices
17
Sandoz
16
Apotex
16
FTC
15
Amgen
15
Appeals
15
Failure To Warn
14
Biologics
14
FDA Approval
14
Manufacturers
14
Popular
12
Antitrust Litigation
12
Commercial Marketing
12
Drug Pricing
12
Healthcare
12
Intellectual Property Protection
12
Mylan Pharmaceuticals
12
Reverse Payment Settlement Agreements
11
Affordable Care Act
11
PLIVA v Mensing
11
Sandoz v Amgen
11
Teva Pharmaceuticals
10
Patent Dance
10
Warning Labels
9
FTC v Actavis
8
Orange Book
8
Preliminary Injunctions
8
Product Exclusivity
8
Trump Administration
7
Actavis Inc.
7
Class Action
7
Corporate Counsel
7
HHS
7
Medicare
7
Notice Requirements
7
Orphan Drugs
7
Patent Applications
7
Personal Jurisdiction
7
Prior Art
6
Declaratory Judgments
6
Draft Guidance
6
Life Sciences
6
Medicaid
6
Product Hopping
6
REMS
6
Sherman Act
6
Summary Judgment
6
USPTO
6
Watson Pharmaceuticals
5
aBLA
5
Antitrust Violations
5
Biologics Price Competition and Innovation Act of 2009
5
Competition
5
Monopolization
5
Mutual Pharmaceuticals v Bartlett
5
Otsuka Pharmaceutical
5
Product Labels
5
Proposed Regulation
5
Safe Harbors
4
Amarin
4
Anti-Competitive
4
CMS
4
Design Defects
4
DOJ
4
Eli Lilly
4
Endo Pharmaceuticals
4
Exclusivity
4
GDUFA
4
GlaxoSmithKline
4
Health Care Providers
4
Inter Partes Review (IPR) Proceeding
4
Jurisdiction
4
No-AG Agreement
4
OIG
4
On-Sale Bar
4
Patent Invalidity
4
Pay-For-Delay
4
Proposed Legislation
4
Standing
3
21st Century Cures Initiative
3
AbbVie
3
Allergan Inc
3
Antitrust Provisions
3
AstraZeneca
3
Bayer
3
Brand
3
Citizen Petitions
3
Classen Immunotherapies
3
Comment Period
3
Congressional Investigations & Hearings
3
Drug Safety
3
Elan Pharmaceuticals
3
Federal Rule 12(b)(6)
3
Healthcare Reform
3
Hospira
3
Hospitals
3
Learned Intermediary
3
Legislative Agendas
3
Licensing Rules
3
Medicare Part B
3
Mensing
3
Merck
3
Multidistrict Litigation
3
NIH
3
Obviousness
3
Off-Label Promotion
3
Pharmacies
3
Pleading Standards
3
Professional Conferences
3
Public Health Service Act
3
Rule-of-Reason Analysis
3
Rulemaking Process
3
Spectrum
3
Takeda Pharmaceuticals
3
Telehealth
3
Trademarks
3
User Fees
2
Allergan v Sandoz
2
America Invents Act
2
Antitrust Injuries
2
Biotechnology
2
Canada
2
Cancer
2
Causation
2
CDC
2
Cephalon
2
Chevron Deference
2
China
2
CHIP
2
Class Certification
2
Clinical Trials
2
Co-Op
2
Congressional Committees
2
Contraceptive Coverage Mandate
2
DaimlerAG
2
DaimlerChrysler v Bauman
2
Dismissals
2
Drug Compounding
2
Durable Medical Equipment
2
Duty to Deal
2
E-Cigarettes
2
Enforcement Actions
2
EU
2
False Advertising
2
False Claims Act (FCA)
2
FDA Commissioner
2
Federal Budget
2
First Amendment
2
Food Safety
2
Foreign Manufacturers
2
Free Speech
2
General Jurisdiction
2
Health Information Technologies
2
Induced Infringement
2
Injunctive Relief
2
Innovator Liability
2
Intellectual Property Litigation
2
INTERPOL
2
Medicare Part D
2
Medicare Prescription Drug Improvement and Modernization Act (MMA)
2
MedPAC
2
Medtronic
2
Mental Health
2
Motion to Dismiss
2
Motion To Stay
2
New Legislation
2
Novartis
2
Off-Label Use
2
Opioid
2
Patent Trial and Appeal Board
2
Permanent Injunctions
2
PHRMA
2
Product Defects
2
Putative Class Actions
2
Rebates
2
Roxane Laboratories
2
SEC
2
Section 340B
2
SNDAs
2
Standard of Review
2
Substance Abuse
2
Suppliers
2
Telemedicine
2
Transfer of Venue
2
TRO
2
Twombly/Iqbal Pleading Standard
2
Unfair Competition
2
Websites
2
Wyeth
1
35 U.S.C. § 271(e)(1)
1
3D Printing
1
510(k) RTA
1
Abbott Laboratories
1
ACOs
1
Actos
1
Advance Notice
1
Alternative Payment Models (APM)
1
Amended Complaints
1
Amended Regulation
1
Anti-Monopoly
1
Antibiotics
1
Antitrust Conspiracies
1
App Developers
1
Article III
1
Attorney Generals
1
Aurobindo Pharmaceuticals
1
Australia
1
Automatic Enrollment
1
Barack Obama
1
Best Practices
1
Bifurcation
1
Biopharmaceutical
1
Bipolar Disorder
1
Boehringer
1
Books
1
BPCI
1
Burden of Proof
1
CA Supreme Court
1
Cadillac Tax
1
CAFC
1
Cartwright Act
1
Carve Out Provisions
1
Center for Drug Evaluation and Research (CDER)
1
Cipro
1
Civil Monetary Penalty
1
Claim Construction
1
Clearance
1
CLIA
1
Collateral Estoppel
1
Community Trademark
1
Compliance
1
Confidential Information
1
Conflicting Proposals
1
Congressional Budget Office
1
Copyright
1
Copyright Infringement
1
Corrective Actions
1
Cost-Sharing
1
Counterclaims
1
Counterfeit Drugs
1
Counterfeiting
1
Covenant Not to Sue
1
Covered Business Method Patents
1
Daiichi Sankyo
1
Defect
1
Delaware General Corporation Law
1
Department of Veterans Affairs
1
Device Classification
1
DHS
1
Diagnostic Tests
1
Dietary Supplements
1
Direct Purchasers
1
Disclosure
1
Disclosure Requirements
1
Discovery Rule
1
Disgorgement
1
Doctrine of Equivalents
1
DOHA
1
DOL
1
DQSA
1
Drug & Alcohol Abuse
1
Duty to Warn
1
EAR
1
EHR
1
Elder Issues
1
Email
1
Employer Mandates
1
Enforcement
1
Evidence Suppression
1
Exceptional Case
1
Excessive Pricing
1
Executive Orders
1
Expert Testimony
1
Exports
1
False Evidence
1
FCPA
1
FD&C Act
1
FDA Reauthorization Act
1
FDASIA
1
Federal Question Jurisdiction
1
Federal Rule 12(b)(1)
1
Federal Rules of Civil Procedure
1
Fee-for-Service
1
Filing Fees
1
Final Rules
1
First Sale Doctrine
1
Food and Drug Administration Amendments Act (FDAAA)
1
Food Labeling
1
Food Recalls
1
Foreign Corporations
1
Foreseeability
1
Forum Shopping
1
Fraudulent Concealment
1
FTEs
1
Generic
1
Genzyme
1
Gilead Sciences
1
Goodyear
1
Government Investigations
1
Grable Factors
1
Health Insurance
1
Health Safety
1
Highmark v. Allcare
1
HIPAA
1
Hoffman LaRoche
1
Home Health Care
1
ICD-10
1
Implied Preemption
1
Imports
1
Information Reports
1
Informed Consent
1
Innovation
1
Inspections
1
International Arbitration
1
International Harmonization
1
International Treaties
1
Inventions
1
Investigational New Drug Application (IND)
1
Investors
1
IPAB
1
IRF Claim Processing
1
Issue Preclusion
1
Janssen Pharmaceuticals
1
Johnson & Johnson
1
Justiciable Controversy
1
Kickbacks
1
Lanham Act
1
Leave to Amend
1
License Agreements
1
Licenses
1
Long Term Care Facilities
1
Manufacturing Defects
1
Market Manipulation
1
Marketing
1
Medical Foods
1
Medical Research
1
Medicare Modernization Act
1
Method Claims
1
Misrepresentation
1
Mootness
1
Motion for Reconsideration
1
Motion To Centralize
1
Motion to Compel
1
Native American Issues
1
Negligence
1
New Guidance
1
New Regulations
1
New Trial
1
Nexus
1
Nike
1
NJ Supreme Court
1
Nominations
1
Non-Grandfathered Health Plans
1
Notice of Intent
1
Notifications
1
Numerosity
1
Nursing Homes
1
Nutritional Supplements
1
OCR
1
Octane Fitness v. ICON
1
Open Enrollment
1
OPPS
1
Out-of-State Companies
1
Out-of-State Judgments
1
OxyContin
1
PACE
1
Par Pharmaceutical
1
Patent Term Extensions
1
Patent-Misuse
1
Pending Legislation
1
Pharmacist
1
PHSA
1
Physician Fee Schedule
1
Physician Medicare Reimbursements
1
Post-Grant Review
1
Post-Market Approval
1
Prescription Drug Coverage
1
Presidential Elections
1
Price Transparency
1
Price-Fixing
1
Private Right of Action
1
Prometheus
1
Proposed Amendments
1
Proposed Rules
1
Public Hearing
1
Public Meetings
1
Public Performance Rights
1
Public Use
1
Qui Tam
1
RanBaxy
1
Reauthorization
1
Recordkeeping Requirements
1
Registration Requirement
1
Regulatory Standards
1
Renewal Fees
1
Repeal
1
Res Ipsa Loquitur
1
Research and Development
1
Restraining Orders
1
Reversal
1
Reverse Payments
1
RICO
1
Risk Assessment
1
Risk Management
1
Risk Mitigation
1
Rule 23
1
Rural Areas
1
Rural Health Care Program
1
SAMHSA
1
Sanofi
1
Senate Judiciary Committee
1
Settlement
1
Settlement Agreements
1
Sham Citizen Petitions
1
Sham Litigation Exception
1
Skilled Nursing Facility
1
SmithKline Beecham
1
Social Security
1
Specific Jurisdiction
1
Spoliation
1
State Health Insurance Exchanges
1
State Law Tort Claims
1
Subject Matter Jurisdiction
1
Supply Chain
1
Tax Credits
1
Tobacco Regulations
1
Trade Secrets
1
Trademark Registration
1
Trademark Searches
1
Transvaginal Mesh
1
Two-Midnight Rule
1
U.S. Treasury
1
Uniform Commercial Code (UCC)
1
Universal Health Services Inc v United States ex rel Escobar
1
Vaccinations
1
Veterans
1
Veterinary Products
1
Warner Chilcott
1
Webinars
1
Whistleblowers
1
WIPO
1
Women's Preventable Healthcare Mandates
1
Work Plans
1
WTO
1
Young Lawyers